Eliem Therapeutics, Inc. (ELYM) Tops Q3 EPS by 6c

Eliem Therapeutics, Inc. (NASDAQ: ELYM) reported Q3 EPS of ($0.37), $0.06 better than the analyst estimate of ($0.43).

For earnings history and earnings-related data on Eliem Therapeutics, Inc. (ELYM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• SanDisk upgraded at JPMorgan after investor day; shares climb